Evidence map›Paper›PMID 21904675›Full record

ArticlePulmonary medicine2011

The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation.

Annelieke W M Paantjens, Ed A van de Graaf, Johanna M Kwakkel-van Erp, Tineke Hoefnagel, Walter G J van Ginkel, Farzia Fakhry, Diana A van Kessel, Jules M M van den Bosch, Henny G Otten

Open access · goldAbstract read
In one paragraph

Article in Pulmonary medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Prospective assessment of pre-existing andFrontiers in immunology · 2023
    Article
  2. Review
  3. Growing Trans-Species Islets in Tumor Extract-Remodeled Testicles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Annelieke W M PaantjensDepartment of Immunology, University Medical Centre Utrecht, 3584 EA Utrecht, The Netherlands.
Ed A van de Graaf
Johanna M Kwakkel-van Erp
Tineke Hoefnagel
Walter G J van Ginkel
Farzia Fakhry
Diana A van Kessel
Jules M M van den Bosch
Henny G Otten
University Medical Center Utrecht · NLSt. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of IgG HLA antibodies after lung transplantation (LTx) is considered to be a major risk factor for the development of chronic rejection, represented by the bronchiolitis obliterans syndrome (BOS). It has recently been observed that elevated levels of IgM HLA antibodies also correlates with the development of chronic rejection in heart and kidney transplantation. This study investigates the relationship between IgM and IgG antibodies against HLA and MICA after lung transplantation. Serum was collected from 49 patients once prior to transplantation and monthly for up to 1 year after lung transplantation was analyzed by Luminex to detect IgM and IgG antibodies against HLA and MICA. The presence of either IgM or IgG HLA and/or MICA antibodies prior to or after transplantation was not related to survival, gender, primary disease, or the development of BOS. Additionally, the production of IgG alloantibodies was not preceded by an increase in levels of IgM, and IgM levels were not followed by an increase in IgG. Under current immune suppressive regimen, although the presence of IgM antibodies does not correlate with BOS after LTx, IgM( high) IgG( low) HLA class I antibody titers were observed more in patients with BOS compared to patients without BOS.

Identifiers

PMID21904675
PMCPMC3166568
OpenAlexW2103620254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.